The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy | Journal of Hematology & Oncology | Full Text

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy | Journal of Hematology & Oncology | Full Text

Journal of Hematology & Oncology

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy

• Ji Wang, 
• Shuduo Xie, 
• Jingjing Yang, 
• Hanchu Xiong, 
• Yunlu Jia, 
• Yulu Zhou, 
• Yongxia Chen, 
• Xiaogang Ying, 
• Cong Chen, 
• Chenyang Ye, 
• Linbo Wang & 
• Jichun Zhou 

Journal of Hematology & Oncologyvolume 12, Article number: 81 (2019) | Download Citation

Abstract

Background

Tamoxifen resistance remains a clinical challenge for hormone receptor-positive breast cancer. Recently, dysregulations in autophagy have been suggested as a potential mechanism for tamoxifen resistance. Although the long noncoding RNA H19 is involved in various stages of tumorigenesis, its role in tamoxifen resistance remains unknown. Here, we assessed the role of H19 in the development of tamoxifen-resistant breast cancer.

Methods

Quantitative real-time PCR analyzed expression of H19 in tamoxifen-resistant breast cancer tissues. Knockdown of H19 was used to assess the sensitivity to tamoxifen in vitro and in vivo. Both knockdown and overexpression of H19 were used to analyze the status of autophagy. Real-time quantitative methylation-specific polymerase chain reaction, chromatin immunoprecipitation, immunofluorescence, and Western blot were used to explore the tamoxifen resistance mechanism of H19.

Results

In this study, we observed that the expression of H19 was substantially upregulated in tamoxifen-resistant breast cancer cell line and tumor tissues, and knockdown of H19 enhanced the sensitivity to tamoxifen both in vitro and in vivo. Furthermore, knockdown of H19 significantly inhibited autophagy in MCF7 tamoxifen-resistant (MCF7/TAMR) cells. Conversely, overexpression of H19 promoted autophagy. Interestingly, overexpression of H19 in MCF7 tamoxifen-sensitive cells could recapitulate tamoxifen resistance. Moreover, an increase in methylation in the promoter region of Beclin1 was observed in MCF7/TAMR-shH19 cells. In the double knockdown groups, both shH19+shSAHH and shH19+shDNMT3B rescued the Beclin1 promoter region methylation levels and reactivated autophagy functions. A chromatin immunoprecipitation assay further validated that DNMT3B binds to the Beclin1 promoter region and the knockdown of H19 increases this binding.

Conclusions

Our findings demonstrate that H19 induces autophagy activation via the H19/SAHH/DNMT3B axis, which could contribute to tamoxifen resistance in breast cancer.